| Net Cash Provided by (Used in) Operating Activities |
$3,646,585 |
USD |
-2933% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$630,436 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
76,802,872 |
shares |
1103% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$21,936,274 |
USD |
264% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$74,764,606 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$75,193,833 |
USD |
9643% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$3,755 |
USD |
-67% |
Q1 2024 |
Q1 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$3,755 |
USD |
|
Q1 2024 |
Q1 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.045 |
pure |
0% |
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
$431,799,677 |
USD |
2450% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
-100% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$320 |
USD |
-100% |
Q3 2024 |
Q3 2024 |